Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Double bottom, PSO, stomping out the low...... whatever you want to call it but, up up we go!!
Where is bottom? 65? 70? 75? We need a base to form, so we can make this run again......
I know - I check in periodically, but no one posts in here.
I enjoy Clay’s analysis. Keep up the good work bro!
Now that I’ve looked at the daily chart. Looks bullish and I also see a hammer right on support. Now we need the bulls to push us up.
Hammer at the end of a trend? This is where you want to see a hammer. Hammering out support!!
Hammer on support? If not, a hammer in the middle of nowhere doesn’t mean much. Post a chart.....
Evercore ISI initiation and $25.00 price target.
Aurora Cannabis Inc Expected to Post FY2020 Earnings of ($0.44) Per Share (TSE: ACB) https://va.topbuzz.com/s/RcUkbh
Go away!
Where’s my boy Clay?? Love his analysis.
We need some really big news about now!! Clay’s chart says it all!! We need the bulls to show up big time and squash the bears!!! All we need is some news!! Come on ACB give us something.
AURORA CANNABIS STOCK IS RISING. A CRITICAL ANALYST SAYS TO HOLD OFF ON BETS AGAINST IT. -- BARRONS.COM
BY Dow Jones & Company, Inc.
— 2:27 PM ET 02/14/2020
Aurora Cannabis (ACB) stock was rising again on Friday. An analyst at MKM Partners sees fewer risks -- at least until the company reports annual results in September -- and advised investors not to bet against the stock. Where we were. A disappointing 2019 for cannabis stocks continued into the new year for Aurora Cannabis (ACB). Aurora stock has shed 78% of its value compared with a year ago.
The company announced write-downs, cost-cutting measures, and the retirement of CEO Terry Booth earlier this month. It also gave investors a preliminary look at its disappointing December quarter results, disclosed in full on Thursday.
Cash burn has been a major concern for the broader industry. The company told investors last week that it promised its creditors that it will turn cash-flow positive by the September 2020 quarter, with 50 million Canadian dollars (US$ 37.7 million) in earnings before interest, taxes, depreciation, and amortization in fiscal year 2021.
Aurora's shares actually rose Thursday after the company reported the numbers. A good deal of the disappointments were already priced in given the stock's drop following the preliminary announcement. What's new. MKM Partners analyst Bill Kirk upgraded his rating on Aurora stock to Neutral from Sell. Don't confuse that with a vote of confidence. "By no means do we recommend owning the stock," Kirk wrote. But in the near term, he expects there to be fewer factors that could drive the shares lower. As a result, he said, MKM " can't recommend pressing a short thesis," or bets that the stock will fall in the near term. Goodwill and intangibles won't be required to be reevaluated until the end of Aurora's fiscal year on June 30. Any write-downs that result would be disclosed with the company's earnings for the fiscal fourth quarter, which are expected in September. That lowers the risk of any such bad news in the near term, according to Kirk.
Aurora stock was up 3% to $1.52 early Friday afternoon, while the S&P 500 was slightly down. The ETFMG Alternative Harvest ETF (MJ), an exchange-traded fund with exposure to the broader marijuana trade, was up 2.3%. Looking ahead. Kirk doesn't think Aurora will be profitable in terms of cash flow in the September quarter. He also expects selling, general, and administrative expenses to be higher than the company and analysts hope. He also anticipates further write- downs related to some of its assets in Canada."By our count this is the third timeline Aurora has given for positive EBITDA, and they have Just (2Q'20) posted the worst EBITDA loss in company history," he wrote. "To believe their guidance, you have to assume Aurora didn't take prior efforts seriously, but are now appropriately committed AND the task is achievable. We aren't convinced."Kirk called prior forecasts from Aurora's management some of the most optimistic, and ultimately incorrect, in the industry. He pointed out that notable executives like Booth and former chief corporate officer Cam Battley are no longer leading the company. "We believe this optimism, particularly around growth and profitability created an organization with a bloated cost structure and a capital structure with burdensome convertibles and a heavily diluted equity base, " he wrote. "To the company's credit, Aurora does have some strong IP from its MedReleaf acquisition and some strong brands in San Rafael and Whistler (both acquired)." Though Kirk upgraded his rating on the stock to Neutral, he lowered his fair-value estimate to C$1.75, from C$2.
--Write to Connor Smith at
connor.smith@barrons.com
.
(END) Dow Jones Newswires
02-14-20 1427ET
Copyright (c) 2020 Dow Jones & Company, Inc.
Poor shorties!!
Aurora Cannabis Announces Appointment of Two New Independent Directors
Source: PR Newswire (US)
Friedmann and Detlefsen Bring Significant Experience in Consumer Products and Marketing
NYSE | TSX : ACB
EDMONTON, Feb. 6, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today appointed two new independent directors, Lance Friedmann and Michael Detlefsen (together the "New Directors"). The New Directors term begins immediately.
Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)
Executive Chairman and Interim CEO Michael Singer stated, "We are pleased to welcome Lance Friedmann and Michael Detlefsen as independent members to the board at this critical time in our transformation. We expect to see cannabinoids grow as a category in consumer products and believe their depth of experience and strong track records of successful brand development and operational business transformation will provide helpful insights to our executive team. With the addition of Messrs. Friedmann and Detlefsen, Aurora has expanded its Board, independent directors."
About Lance Friedmann
Over Mr. Friedmann's 25 year experience with Kraft Foods and Mondelez International, Inc. he held a number of roles of progressing scope and responsibility focused on marketing, strategy, and customer insights across the U.S., Latin America, and Asia. His experience includes senior management of Kraft Foods' marketing-related and corporate marketing programs, for Canada, Mexico and Puerto Rico, and Health & Wellness. Notably, he played a critical role in the launch of the "Sensible Solutions" product line, and subsequently led Mondelez's $12 billion global biscuits category, including Oreo, the world's #1 biscuit brand.
About Michael Detlefsen
Mr. Detlefsen is currently the Managing Director of Pomegranate Capital Advisors, an active investor advisory firm with holdings in the branded consumer and B2B food sectors, agribusiness and financial services. He brings over 30 years as a senior executive and investor in the global consumer products, agri-food, logistics and transportation, and telecom sectors. He has a strong track record of developing and executing strategies to accelerate growth, transform operations, improve capital allocation and substantially enhance corporate performance. Mr. Detlefsen currently serves on the boards of SunOpta (NASDAQ: STKL) and Phoenix Canada Oil Company (TSX:PCO), and is the Executive Chair of Elevation Brands, a privately-held consumer products company focused on gluten-free and allergen-friendly foods. He is also a Governor of the Royal Ontario Museum, Canada's largest museum of natural history and world cultures. Mr. Detlefsen previously served on the boards of State Street and Multi-Marques in Canada and CWC Communications PLC in the UK.
CEO Retirement and Succession & Business Transformation Plan
Aurora also announced today in a separate announcement a CEO Retirement and Succession & Business Transformation Plan to better align fixed costs and capital expenditures with current market conditions. These combined changes will significantly accelerate Aurora's path to cash flow break even while still maintaining the Company's ability to capitalize on the long-term, global cannabinoids market opportunity. Aurora will host a conference call today at 5:00 p.m. Eastern Time to discuss these business updates.
CEO Succession & Business Transformation Plan Conference Call
DATE: Today, Thursday, February 6, 2020
TIME: 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time
WEBCAST: http://public.viavid.com/index.php?id=138052
REPLAY: (844)-512-2921 or (412)-317-6671
PIN NUMBER: 13698974
Available until 11:59 p.m. Eastern Time Thursday, February 20, 2020
About Aurora
Headquartered in Edmonton, Alberta, Canada with sales and operations in 25 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high-quality consistent product. Designed to be replicable and scalable globally, our production facilities are designed to produce cannabis at significant scale, with high quality, industry-leading yields, and low-per gram production costs. Each of Aurora's facilities is built to meet European Union Good Manufacturing Practices ("EU GMP") standards. Certification has been granted to Aurora's first production facility in Mountain View County, the MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland. All Aurora facilities are designed and built to the EU GMP standard.
In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 17 wholly owned subsidiary companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, Chemi Pharmaceutical, and Hempco – Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ), High Tide Inc. (CSE: HITI), EnWave Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group (private), and Wagner Dimas (private).
Aurora's Common Shares trade on the TSX and NYSE under the symbol "ACB", and is a constituent of the S&P/TSX Composite Index.
Forward Looking Statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions, estimates and assumptions of management in light of management's experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 10, 2019 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-announces-appointment-of-two-new-independent-directors-301000687.html
SOURCE Aurora Cannabis Inc.
Copyright 2020 PR Newswire
Glad I got out of this POS
Buy buy buy
Gunna be interesting tomorrow. Gunna hit a wall at .25..... might be a good play from .23 and a quick flip at .25 resistance.
Burn shorts, burn!!!
Manipulation at its finest!!
Good to be in the news:
https://www.benzinga.com/markets/cannabis/20/01/15068626/how-cbd-got-into-the-world-of-mixed-martial-arts-mma via Benzinga iOS
I still like my 1.91 shares. Sold half my position this morning for a nice profit.....I agree with others, I think we’ll see a little green tomorrow......IMO
I’m lovin my 1.91 shares from yesterday. Taking a little profit today.......
Let’s try that again:
The Best Pot Pick Could Actually Be Aurora Cannabis Stock http://va.topbuzz.com/s/bcjjSr